Citrine Global Corp Stock Price, News & Analysis

Citrine Global Corp (CTGL), doing business as SkyTech Orion Global, announced that CEO and Chairwoman Ora Elharar Soffer will deliver a keynote at UVID 2025 on Nov 17, 2025.

The company will exhibit at Booth 14 and showcase the SkyTech Replicator™ modular drone platform and present the SkyTech Center, a planned national UAV innovation and large-scale manufacturing hub in Yeruham, Israel. The Replicator platform is described as a Plug & Fly™ modular system built with NDAA-compliant, U.S.-approved components to support distributed manufacturing across the U.S., Israel, and global partners.

The SkyTech Center initiative is supported by Israel’s Growth Administration and Ministry of Economy and aims to build Blue-and-White production capacity, strengthen exports, and expand U.S.–Israel industrial and defence collaboration.

Citrine Global Corp (OTCQB: CTGL) participated at AUVSI Defense 2025 in Washington, D.C. on Oct 29, 2025, where it launched the SkyTech Replicator™, a modular drone kit that converts into four mission drones and ships in a single tactical case.

The Replicator features a Smart Core Unit control hub, two Smart Arm classes (Light and Endura), swappable batteries, and modular payloads. Stated payload limits are up to 0.5 kg for light arms and up to 2.5 kg for endurance/lift arms. The system is described as tool-less, NDAA-compliant, cable-less, and designed for rapid “Plug & Fly” reconfiguration to deliver ISR, strike, lift, or loitering capabilities.

SkyTech Orion Global Corp. (OTCQB: CTGL) announced a strategic transformation into unmanned systems and defense-grade drone solutions, unveiling the modular SkyTech Replicator™ platform and a proprietary Replication Manufacturing Method.

Key developments: multiple patent filings in the U.S. and Israel (2025); a multi-million-dollar grant from the Israeli Ministry of Economy for the SkyTech Center Israel on ~11,687 sqm in Yeruham; a collaboration with Stratasys for additive manufacturing; and planned assembly centers in Israel and the U.S. to produce thousands of units in Q1 2026. The company is pursuing a strategic capital raise and an eventual NASDAQ uplist.

Citrine Global Corp. (CTGL) has signed a memorandum of understanding (MOU) with MyPlant Bio Ltd. to acquire 55% of its shares for USD 2.44 million. This acquisition aligns with Citrine Global's strategy to lead in plant-based wellness and pharma solutions, leveraging MyPlant’s expertise in botanical drug development. The collaboration aims to enhance Citrine's product lines with scientifically backed formulations, tapping into the growing markets projected to reach USD 625 billion (nutritional supplements) and USD 53 billion (plant-derived drugs) by 2030 and 2026, respectively.

Citrine Global Corp. (OTCQB: CTGL) has filed a provisional patent application for compositions and methods aimed at mitigating side effects from medicinal treatments, aging, and unhealthy lifestyles. The patent, No: 63/418,046, focuses on solutions to common side effects like dryness, headaches, and fatigue. Additionally, the company has announced the launch of the GreenFeels^TM product lines, which include over 100 wellness products and nutritional supplements designed to enhance quality of life. The launch emphasizes plant-based solutions and targets both U.S. and global markets.

Citrine Global Corp. (OTCQB: CTGL) announced that its subsidiary, Cannovation Center Israel Ltd, has filed a provisional patent application with the USPTO. The application focuses on alleviating oral cavity side effects related to medications and unhealthy lifestyles. With over 25% of the population experiencing dry mouth, the company aims to develop plant-based wellness solutions, including their SmokLy™ sprays. Citrine Global's strategy revolves around innovative plant-based products, emphasizing infrastructure for production and sales across North America and Europe.

Citrine Global Corp. (OTCQB: CTGL) announced the appointment of Prof. Itamar Grotto to its Board of Directors and as President of Green Vision Center Israel. Prof. Grotto, a seasoned expert in public health, aims to advance the company's strategy in developing innovative plant-based wellness and pharma solutions. The company has acquired 125,000 square feet of land in southern Israel to establish the Green Vision Center, which will serve as a hub for production and innovation in the plant-based sector. This development is expected to enhance the company's infrastructure and market presence.

Citrine Global Corp. (OTCQB: CTGL), a leader in plant-based wellness solutions, recently shared a Letter to Shareholders from CEO Ora Elharar-Soffer. The company reports significant milestones since its acquisition, including the launch of the Green Side by Side product line in Q1 2022 and the acquisition of a 125,000 sq ft site for its Green Vision Center in Israel. Citrine aims to address common side effects of medications through innovative products and plans to uplist to Nasdaq, positioning itself for transformative growth in the wellness and pharma markets, expected to reach $625 billion by 2030.